These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24134145)

  • 21. A fatal case of erythema necroticans.
    Davis SV; Shenoi SD; Balachandran C; Pai SB
    Indian J Lepr; 2002; 74(2):145-9. PubMed ID: 12708733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythema nodosum leprosum associated with minocycline.
    Travassos AR; Antunes J; Pacheco D; Almeida LS; Filipe P; Marques MS
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):39-41. PubMed ID: 23000940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical presentations of erythema nodosum leprosum: Diagnostic and therapeutic aspects.
    Alakad R; Nofal A; Assaf M
    J Dtsch Dermatol Ges; 2021 Aug; 19(8):1133-1143. PubMed ID: 34033221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I; Dogra S; De D; Saikia UN
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
    Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
    Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dissimulate presentation of histoid Hansen's disease in the form of erythema nodosum leprosum.
    Pathania V; Oberoi B; Baveja S; Shelly D; Venugopal R; Shankar P
    Int J Mycobacteriol; 2019; 8(2):208-210. PubMed ID: 31210170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous ulceration as a presenting feature of type 1 lepra reaction: A case report.
    Hegde P; Jaiswal D; Shetty VM; Pai K; Rao R
    Trop Doct; 2022 Apr; 52(2):354-356. PubMed ID: 35006027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.
    Haslett PA; Roche P; Butlin CR; Macdonald M; Shrestha N; Manandhar R; Lemaster J; Hawksworth R; Shah M; Lubinsky AS; Albert M; Worley J; Kaplan G
    J Infect Dis; 2005 Dec; 192(12):2045-53. PubMed ID: 16288366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
    Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I
    Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual Presentation of Necrotic Erythema Nodosum Leprosum on Scalp: A Case Report.
    Barman KD; Madan A; Garg VK; Goel K; Khurana N
    Indian J Lepr; 2015; 87(1):23-6. PubMed ID: 26591847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in central India.
    Wankhade VH; Debnath P; Singh RP; Sawatkar G; Bhat DM
    Int J Mycobacteriol; 2019; 8(1):29-34. PubMed ID: 30860176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B; Pallapati MS; Tarwater P; Srikantam A
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY; Achirafi A; Flageul B
    J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canadian case report of erythema nodosum leprosum successfully treated with prednisone and thalidomide.
    Saber M; Bourassa-Fulop C; Bouffard D; Provost N
    J Cutan Med Surg; 2010; 14(2):95-9. PubMed ID: 20338126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.